Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis

被引:128
|
作者
Buscariollo, Daniela L. [1 ]
Park, Henry S. [2 ]
Roberts, Kenneth B. [2 ,3 ]
Yu, James B. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
关键词
atypical teratoid rhabdoid tumor; central nervous system; epidemiology; radiotherapy; children; CENTRAL-NERVOUS-SYSTEM; TERATOID/RHABDOID TUMOR; RADIATION-THERAPY; CHILDREN; CHILDHOOD; CHEMOTHERAPY; INFANCY; ATRT;
D O I
10.1002/cncr.27373
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Atypical teratoid rhabdoid tumor (ATRT) is a rare central nervous system malignancy with a poor prognosis that affects mostly young children. Although radiotherapy (RT) historically has been delayed in patients aged <3 years, emerging evidence suggests a role for RT to achieve long-term survivorship. Clinical features and age-dependent trends of RT use were evaluated for patients with ATRT. METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results database was used to identify 144 patients with ATRT from 1973 to 2008. The primary endpoint was median overall survival (OS). Clinical and treatment variables were assessed for an association with OS using Cox proportional hazards models. Landmark analysis was used to correct for immortal time bias of adjuvant RT. RESULTS: The median age at diagnosis was 1 year (range, 0-67 years). Gross total resection of the primary tumor was achieved in 39% of patients, and 33% of patients received RT. From 1992 to 2008, RT use increased 2.4-fold in patients aged =3 years. The median OS for was 10 months. In multivariate analyses, metastatic disease (hazard ratio, 2.83; 95% confidence interval, 1.53-5.23; P = .001) and RT (hazard ratio, 0.10; 95% confidence interval, 0.01-0.73; P = .02) were identified as independent predictors of survival. Landmark analysis confirmed a robust association between RT use and survival, which was attenuated in patients ages 4 to 17 years compared with younger patients. CONCLUSIONS: The current results indicated that RT may offer a significant survival benefit for patients with ATRT and that patients aged =3 years may derive more benefit from initial RT compared with older children. The authors concluded that prospective clinical trials are needed to examine the role of RT in the initial management of ATRT in patients aged <3 years. Cancer 2012. (c) 2011 American Cancer Society.
引用
收藏
页码:4212 / 4219
页数:8
相关论文
共 50 条
  • [21] ANALYSIS OF PATIENTS DIAGNOSED WITH ATYPICAL TERATOID RHABDOID TUMOR OF BRAIN AT TERTIARY CARE CENTER
    Shah, Setu
    Mehta, Maitrik
    Pandya, Akash
    Parikh, Ankita
    NEURO-ONCOLOGY, 2023, 25
  • [22] Clinical characteristics and outcomes of atypical carcinoid (AC) tumor of the lung: A Surveillance, Epidemiology, and End Results database analysis.
    Steuer, Conor Ernst
    Behera, Madhusmita
    Kim, Sungjin
    Chen, Zhengjia
    Pillai, Rathi Narayana
    Owonikoko, Taofeek Kunle
    Khuri, Fadlo Raja
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] OUTCOMES FOR CHILDREN WITH RECURRENT ATYPICAL TERATOID RHABDOID TUMOR: A SINGLE INSTITUTION STUDY
    Carey, Steven
    Huang, Jie
    Acharya, Sahaja
    Orr, Brent
    Onar-Thomas, Arzu
    Michalik, Layna
    Klimo, Paul, Jr.
    Boop, Frederick
    Merchant, Thomas
    Ellison, David
    Robinson, Giles
    Gajjar, Amar
    Upadhyaya, Santhosh
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S72 - S73
  • [24] The Impact of Surgical Resection and Adjuvant Therapy on Survival in Pediatric Patients with Atypical Teratoid/Rhabdoid Tumor: Systematic Review and Pooled Survival Analysis
    Egiz, Abdullah
    Kannan, Siddarth
    Asl, Sarvin Farajzadeh
    WORLD NEUROSURGERY, 2022, 164 : 216 - 227
  • [25] IN VITRO ANALYSIS OF COMBINATION EPIGENETIC THERAPY FOR ATYPICAL TERATOID/RHABDOID TUMOR
    Knipstein, Jeffrey
    Harris, Peter
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2011, 13 : I23 - I23
  • [26] Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience)
    Chen, YW
    Wong, TT
    Ho, DMT
    Huang, PI
    Chang, KP
    Shiau, CY
    Yen, SH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04): : 1038 - 1043
  • [27] Assessment of Treatment Approach and Survival Outcomes in a Modern Cohort of Patients with Atypical Teratoid Rhabdoid Tumour (ATRT)
    Fischer-Valuck, B.
    Chen, I.
    Floberg, J.
    Perkins, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S22 - S23
  • [28] The Impact of Surgical Resection and Adjuvant Therapy on Survival in Pediatric Patients with Atypical Teratoid/Rhabdoid Tumor: Systematic Review and Pooled Survival Analysis
    Egiz, Abdullah
    Kannan, Siddarth
    Asl, Sarvin Farajzadeh
    WORLD NEUROSURGERY, 2022, 164 : 216 - 227
  • [29] Atypical teratoid/rhabdoid tumor with 26-year overall survival Case report
    Takahashi-Fujigasaki, Junko
    Matumoto, Masayoshi
    Kan, Issei
    Oka, Hidehiro
    Yasue, Masaharu
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2012, 9 (04) : 400 - 405
  • [30] RECURRENT MEDULLOBLASTOMA AND ATYPICAL TERATOID RHABDOID TUMOR: PROLONGED SURVIVAL WITH AN ANTIANGIOGENIC COMBINATION THERAPY
    Slavc, Irene
    Peyrl, Andreas
    Chocholous, Monika
    Azizi, Amedeo
    Czech, Thomas
    Dieckmann, Karin
    Haberler, Christine
    Gojo, Johannes
    Rauch, Moritz
    Grylli, Chryssa
    NEURO-ONCOLOGY, 2016, 18 : 103 - 103